Compare · FRES vs ILMN
FRES vs ILMN
Side-by-side comparison of Fresh2 Group Limited (FRES) and Illumina Inc. (ILMN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FRES and ILMN operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN carries a market cap of $40.46B.
- ILMN has hit the wire 8 times in the past 4 weeks while FRES has been quiet.
- ILMN has more recent analyst coverage (25 ratings vs 0 for FRES).
- Company
- Fresh2 Group Limited
- Illumina Inc.
- Price
- -
- -
- Market cap
- -
- $40.46B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2000
- News (4w)
- 0
- 8
- Recent ratings
- 0
- 25
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Latest FRES
- SEC Form 6-K filed by Fresh2 Group Limited
- SEC Form 6-K filed by Fresh2 Group Limited
- Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
- Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq
- SEC Form 6-K filed by Fresh2 Group Limited
- Fresh2 Has Partnered With Over 50 Influencers, Leveraging Key Partnerships To Fresh2's Video E-Commerce Business Is Rapidly Expanding Its Market Presence In The E-Commerce Sector
- Fresh2 Announces Collaboration with Over 50 Influencers in Video E-commerce
- Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
- Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
- Fresh2 Group Limited Announces 1-For-10 Reverse ADS Split, Expected To Become Effective On July 10, 2024
Latest ILMN
- Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
- SEC Form 8-K filed by Illumina Inc.
- Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
- Illumina releases SpliceAI2 to help advance rare disease research
- SEC Form 4 filed by Illumina Inc.
- SEC Form SCHEDULE 13G filed by Illumina Inc.
- Director Meister Keith A. was granted 107 shares, increasing direct ownership by 2% to 6,887 units (SEC Form 4)
- Director Ullem Scott B. was granted 113 shares, increasing direct ownership by 1% to 11,143 units (SEC Form 4)
- Chief Legal Officer Coletti Julie Ann was granted 18,763 shares (SEC Form 4)
- SVP, Chief Technology Officer Barnard Steven covered exercise/tax liability with 408 shares, decreasing direct ownership by 0.99% to 40,927 units (SEC Form 4)